SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-006724
Filing Date
2024-02-14
Accepted
2024-02-14 17:00:22
Documents
2
Period of Report
2024-02-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1559
2 ex24.htm EX-24 10283
  Complete submission text file 0001493152-24-006724.txt   13245
Mailing Address C/O CANCER GENETICS, INC. 201 ROUTE 17 NORTH, 2ND FLOOR RUTHERFORD NJ 07070
Business Address
ROBERTS JOHN A (Reporting) CIK: 0001249872 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40874 | Film No.: 24640095

Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Issuer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)